Author | Hossein Borghaei, DO | OncLive

Author | Hossein Borghaei, DO

Articles

Dr. Borghaei on Second-Line Therapy in SCLC

November 10, 2018

Video

Hossein Borghaei, DO, chief, Division of Thoracic Medical Oncology, director, Lung Cancer Risk Assessment, associate professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses the evolving second line of treatment in small cell lung cancer.

Dr. Borghaei Discusses the PACIFIC Trial in Lung Cancer

February 27, 2018

Video

Hossein Borghaei, DO, chief, Division of Thoracic Medical Oncology, director, Lung Cancer Risk Assessment, associate professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses the PACIFIC trial in patients with non–small cell lung cancer (NSCLC).

Dr. Borghaei on Reporting Immunotherapy-Related AEs in Lung Cancer

January 20, 2017

Video

Hossein Borghaei, DO, chief, Division of Thoracic Medical Oncology, director, Lung Cancer Risk Assessment, associate professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses how physicians can help patients with lung cancer feel more comfortable reporting adverse events (AEs) associated with immunotherapy.

Dr. Borghaei on the Management of Immune-Related Side Effects in Lung Cancer

November 16, 2016

Video

Hossein Borghaei, DO, chief, Division of Thoracic Medical Oncology, director, Lung Cancer Risk Assessment, associate professor, Department of Hematology/Oncology, Fox Chase Cancer Center, discusses the management of slightly rarer side effects that patients with lung cancer can experience when treated with immunotherapy agents.

x